Outcome of COVID-19 in children: results of a 12-month follow-up

At present, there are isolated data on the clinical outcomes of COVID-19 in children, especially those who have experienced asymptomatic and mild forms of infection.

Purpose: to analyze the nature and frequency of postCOVID symptoms in children during 12 months. after recovery.

Materials and methods. The influence of demographic indicators, premorbid background, severity of infection and therapy in the acute period of the disease on the nature and frequency of symptoms in 1079 children who underwent laboratory-confirmed COVID-19 was studied. The results are presented with proportions (%) and calculation of 95% confidence interval according to Klopper-Pearson. Differences between groups were assessed using Pearson’s chi-square test. Differences in the groups were considered statistically significant at p < 0,05.

Results. Health disorders in the post-COVID period were observed in 8,5% of children, more often in school-children aged 7–17 years (68.4%). Concomitant conditions were found in 38,0%. In most cases, the consequences were noted after a mild form of COVID-19 (77.2%), however, 13,0% of patients experienced an asymptomatic form of infection. Among convalescents, changes in the emotional sphere (2,1%), headache (1,8%), symptoms of asthenia (1,6%), cardiovascular (1,5%), dyspeptic (1,3%) were more often observed, cognitive (1,3%) disorders, neurotic disorders (1,0%), less often respiratory (0.8%), endocrine (0,4%) and visual (0,4%) systems, musculoskeletal system were involved (0.2%). Girls were significantly more likely to have vegetative disorders, while boys were significantly more likely to suffer from cognitive functions. Various antiviral therapy options (interferon-alpha, an oral antiviral drug, or a combination thereof) in the acute period of COVID-19 did not affect the possibility of post-COVID disorders, but there was a tendency to increase the frequency in children who did not receive etiotropic treatment (control group). In 14.1% of cases, post-COVID symptoms appeared late – after 5–10 months. after recovery. The course of rehabilitation therapy, including drug treatment and non-drug methods, made it possible to quickly restore the state of health of the observed children.

Conclusion. In most cases, the violations were of a functional nature, due to a disorder of autonomic regulation. Rehabilitation and dispensary observation programs will allow timely restoration of the quality of life of children who have had COVID-19, including in a mild and asymptomatic form.

1. Post-COVID Conditions. Updated July 8, 2021. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html [date of access: 22.01.2022].

2. Vanichkachorn G, Newcomb R, Cowl CT, et al. Post–COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort // Mayo Clinic Proceedings. 2021. Vol. 6, N 7. P. 1782-1791. https://doi.org/10.1016/j.mayocp.2021.04.024

3. Salamanna F, Veronesi F, Martini L, et al. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data // Front. Med. 2021. https://doi.org/10.3389/fmed.2021.653516

4. Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection. A Systematic Review. // JAMA. 2021. Vol. 4, N 10. e2128568. doi:10.1001/jamanet-workopen.2021.28568

5. Augustin M, Schommers Ph, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. // Lancet Reg Health Eur. 2021. Vol. 6. e100122. doi: 10.1016/j.lanepe.2021.100122

6. Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19 // JAMA. 2020. Vol. 324, N. 6. P. 603-605. doi:10.1001/jama.2020.12603

7. Huang Ch, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study // Lancet. 2021. Vol. 397, N. 10270. P. 220–232. https://doi.org/10.1016/S0140-6736(20)32656-8

8. Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset // Clinical and Infection. 2021. Vol. 27, N.2. P 258-263. https://doi.org/10.1016/j.cmi.2020.09.052

9. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome // Nat Med. 2021. Vol. 27, N. 4. P. 601-615. doi: 10.1038/s41591-021-01283-z

10. Mezhdunarodnaya statisticheskaya klassifikaciya boleznej i problem, svyazannyh so zdorov’em (MKB-10). https://mkb-10.com/index.php?pid=23014 [date of access: 22.01.2022] (In Russian).

11. Li M-Y, Li L, Zhang Y, Wang X-Sh. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues // Infect Dis Poverty. 2020. Vol. 9, N. 1. e 45. doi:10.1186/s40249-020-00662-x.

12. 12. Ivanov D.O., Chernova T.M., Pavlova E.B., et al. Coronaviral infection. Pediatrician. 2020; 11(3): 109-117. – doi: 10.17816/PED113109-117

13. Chippa V, Aleem A, Anjum F. Post-Acute Coronavirus (COVID-19) Syndrome. – StatPearls Publishing, 2021. https://www.ncbi.nlm.nih.gov/books/NBK570608/ [дата доступа: 22.01.2022].

14. Chernova T.M., Pavlova E.B., Timchenko V.N. et al. Clinical and epidemiological characteristics and effectiveness of antiviral therapy for COVID-19 in children: The experience of the first year of the pandemic. Acta biomedica scientifica. 2021; 6(6-2):18-28. doi: 10.29413/ABS.2021-6.6-2.3 (In Russian).

15. Leidman E, Duca LM, Omura JD, et al. COVID-19 Trends Among Persons Aged 0–24 Years — United States, March 1–December 12, 2020. / CDC. Morbidity and Mortality Weekly Report (MMWR). Weekly /January 22. 2021. Vol. 70, N. 3. P 88–94. https://www.cdc.gov/mmwr/volumes/70/wr/mm7003e1.htm [date of access: 22.01.2022].

16. Lobzin Yu.V., Vilnits A.A., Kostik M.M. et al. Pediatric multisystem inflammatory syndrome associated with a new coronavirus infection: unresolved issues. Journal Infectology. 2021;13(1):13-20. https://doi.org/10.22625/2072-6732-2021-13-1-13-20 (In Russian).

17. Say D, Crawford N, McNab S, et al. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease // Lancet Child Adolesc Health. 2021. Vol. 5, N. 6. P. 22-23. doi: 10.1016/S2352-4642(21)00124-3

18. Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study // Eur Respir J. 2021. e2101341. doi: 10.1183/13993003.01341-2021

19. Denina M, Pruccoli G, Scolfaro C, et al. Sequelae of COVID-19 in Hospitalized Children: A 4-Months Follow-Up // Pediatr Infect Dis J. 2020. Vol. 39, N. 12. P. 458-459. doi: 10.1097/INF.0000000000002937

20. Avdeev S.N., Adamyan L.V., Alekseeva E.I., Bagnenko S.F., Baranov A.A., Baranova N.N. et al. Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19). Vremennye metodicheskie rekomendacii – Versiya 11 (07.05.2021): 224 s. – https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/055/735/original/BМР_COVID-19.pdf (In Russian).

21. Dohov M.A., Tihomirova A.A., Vaulin G.F. Neparametricheskie kriterii v programme «Statistica». SPb.: SPbGPMU, 2019: 40 s. – http://library.gpmu.org/edoc/pdf/2019/file000290.pdf (In Russian).

22. Bolay H, Gül A, Baykan. B. COVID-19 is a Real Headache! // Headache. 2020. Vol. 60. N. 7. P. 1415-1421. doi: 10.1111/head.13856.

23. Kamrath C, Mönkemöller K, Biester T, et al. Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany // JAMA. 2020. Vol. 324, N. 8. P. 801-804. doi:10.1001/jama.2020.13445

24. Chekhlabi, Haoudar A, Echcharii N, et al. New-Onset Diabetes with Ketoacidosis Precipitated by COVID-19 in Children: A Report of Two Cases // Case Rep Pediatr. 2021. Vol. 2021. Р. 5545258. doi: 10.1155/2021/5545258

25. Rubino F, Amiel SA, Zimmet P, et al. New-Onset Diabetes in Covid-19 // N Engl J Med. 2020. Vol. 383, N. 8. P.789-790. doi: 10.1056/NEJMc2018688

26. Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID-19: Causality or coincidence? A report of three cases // J Med Virol. 2020. doi: 10.1002/jmv.26339

27. Vrach rasskazala, chto u perenesshih koronavirus chasto uhudshaetsya zrenie. Ren.tv. 28.11.2021. https://ren.tv/news/v-rossii/908924vrach-rasskazala-chto-u-perenesshikh-koronavirus-chasto-ukhudshaetsia-zrenie [date of access: 22.01.2022] (In Russian).